Kimberley Kavanagh

Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study

Kimberley Kavanagh, Kevin G. Pollock, Kate Cuschieri et al. · The Lancet Infectious Diseases · 2017 · 258 citations · Full text

Vaccination, Cervical Health, Human Papillomavirus Vaccines +7

Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

Timothy Palmer, Lynn Wallace, Kevin Pollock et al. · BMJ · 2019 · 235 citations · Full text

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types

Kimberley Kavanagh, Kevin Pollock, A Potts et al. · British Journal of Cancer · 2014 · 182 citations · Full text

Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland

Kevin G. Pollock, Kimberley Kavanagh, A Potts et al. · British Journal of Cancer · 2014 · 159 citations · Full text

Impact of healthcare-associated infection on length of stay

Sally Stewart, Chris Robertson, Jiafeng Pan et al. · Journal of Hospital Infection · 2021 · 142 citations · Full text